Novel therapy for locally advanced triple-negative breast cancer
To evaluate a novel therapy for triple-negative breast cancer (TNBC), the biological responses to vitamin K3 (VK3) should be considered with the understanding of the features of breast cancer. In human breast cancer cell lines, the effects of VK3 on cell growth inhibition and the cellular signaling...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
D.A. Spandidos
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583525/ |